Ernesta Audisio

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia”.

Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia

Leukemia & Lymphoma(2025)10.1080/10428194.2024.2431878

N/A

0.292DataRank · unranked

6 citations

Agnieszka Wierzbowska, Thomas Cluzeau, Kamel Laribi, Christian Recher, Jaroslaw Czyz +13 more

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy

Haematologica(2024)10.3324/haematol.2024.285448

N/A

0.241DataRank · unranked

4 citations

Erika Borlenghi, Mark R. Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio +34 more